Fisher & Paykel Healthcare Corporation Ltd (AU:FPH) — Market Cap & Net Worth
Market Cap & Net Worth: Fisher & Paykel Healthcare Corporation Ltd (FPH)
Fisher & Paykel Healthcare Corporation Ltd (AU:FPH) has a market capitalization of $12.98 Billion (AU$18.34 Billion) as of April 19, 2026. Listed on the AU stock exchange, this Australia-based company holds position #1660 globally and #29 in its home market, demonstrating a -2.74% decrease in market value over the past year.
Market capitalization, also known as net worth in stock markets, is calculated by multiplying Fisher & Paykel Healthcare Corporation Ltd's stock price AU$31.23 by its total outstanding shares 587262856 (587.26 Million).
Fisher & Paykel Healthcare Corporation Ltd Market Cap History: 2015 to 2026
Fisher & Paykel Healthcare Corporation Ltd's market capitalization history from 2015 to 2026. Data shows growth from $3.04 Billion to $12.98 Billion (17.02% CAGR).
Index Memberships
Fisher & Paykel Healthcare Corporation Ltd is a constituent of 6 market indices:
| Index | Total Market Cap | Weight (%) | Rank by Market Cap |
|---|---|---|---|
|
Australia All Ordinaries
AORD
|
$1.55 Trillion | 0.84% | #26 of 495 |
|
S&P/ASX 100
ATOI
|
$1.39 Trillion | 0.93% | #26 of 100 |
|
S&P/ASX 200
AXJO
|
$1.40 Trillion | 0.93% | #25 of 200 |
|
S&P/ASX 200 Accumulated
AXJOA
|
$1.40 Trillion | 0.93% | #25 of 200 |
|
S&P/ASX 300
AXKO
|
$1.63 Trillion | 0.79% | #27 of 300 |
|
S&P/ASX Midcap 50
AXMD
|
$241.64 Billion | 5.37% | #4 of 50 |
Weight: Fisher & Paykel Healthcare Corporation Ltd's market cap as a percentage of total index value. Rank: Position among all constituents by market cap.
Fisher & Paykel Healthcare Corporation Ltd Market Cap to Earnings & Revenue Ratios Timeline
This chart shows how Fisher & Paykel Healthcare Corporation Ltd's valuation ratios have evolved. The Price to Sales (P/S) ratio compares market cap to revenue, while the Price to Earnings (P/E) ratio compares market cap to net income. Lower values may indicate a more undervalued company relative to its financial performance.
Latest Price to Sales (P/S) Ratio
10.60x
Fisher & Paykel Healthcare Corporation Ltd's market cap is 10.60 times its annual revenue
Latest Price to Earnings (P/E) Ratio
35.97x
Fisher & Paykel Healthcare Corporation Ltd's market cap is 35.97 times its annual earnings
What These Ratios Tell Investors:
- Price to Sales (P/S) Ratio: Shows how much investors are paying for each dollar of the company's sales. Lower P/S ratios may indicate undervaluation.
- Price to Earnings (P/E) Ratio: Shows how much investors are paying for each dollar of the company's earnings. This is one of the most common valuation metrics.
- Trends in these ratios over time can indicate changing investor sentiment about the company's future growth prospects.
- Industry comparison provides context for whether the company is valued higher or lower than peers.
| Year | Market Cap (USD) | Revenue (USD) | Net Income (USD) | P/S Ratio | P/E Ratio |
|---|---|---|---|---|---|
| 2016 | $3.05 Billion | $738.75 Million | $143.43 Million | 4.12x | 21.23x |
| 2017 | $4.86 Billion | $796.79 Million | $169.15 Million | 6.09x | 28.71x |
| 2018 | $4.75 Billion | $907.09 Million | $190.20 Million | 5.24x | 24.97x |
| 2019 | $8.23 Billion | $1.03 Billion | $209.20 Million | 7.99x | 39.32x |
| 2020 | $12.18 Billion | $1.23 Billion | $287.30 Million | 9.87x | 42.39x |
| 2021 | $12.16 Billion | $1.97 Billion | $524.20 Million | 6.17x | 23.20x |
| 2022 | $8.64 Billion | $1.68 Billion | $376.90 Million | 5.14x | 22.93x |
| 2023 | $9.00 Billion | $1.59 Billion | $250.30 Million | 5.67x | 35.96x |
| 2024 | $14.52 Billion | $1.74 Billion | $132.60 Million | 8.33x | 109.52x |
| 2025 | $13.57 Billion | $1.28 Billion | $377.20 Million | 10.60x | 35.97x |
Competitor Companies of FPH by Market Capitalization
Companies near Fisher & Paykel Healthcare Corporation Ltd in the global market cap rankings as of April 19, 2026.
Key companies related to Fisher & Paykel Healthcare Corporation Ltd by market ranking:
- Intuitive Surgical Inc (NASDAQ:ISRG): Ranked #117 globally with a market cap of $166.63 Billion USD.
- EssilorLuxottica S. A. (PA:EL): Ranked #177 globally with a market cap of $116.77 Billion USD ( €99.88 Billion EUR).
- ESSILORLUXOTTICA 1/2/O.N. (F:ESLC): Ranked #236 globally with a market cap of $93.24 Billion USD ( €79.76 Billion EUR).
- HOYA Corporation (F:HYB): Ranked #467 globally with a market cap of $51.10 Billion USD ( €43.71 Billion EUR).
| Rank | Company | Symbol | Market Cap | Price |
|---|---|---|---|---|
| #117 | Intuitive Surgical Inc | NASDAQ:ISRG | $166.63 Billion | $469.21 |
| #177 | EssilorLuxottica S. A. | PA:EL | $116.77 Billion | €215.70 |
| #236 | ESSILORLUXOTTICA 1/2/O.N. | F:ESLC | $93.24 Billion | €101.00 |
| #467 | HOYA Corporation | F:HYB | $51.10 Billion | €159.00 |
Fisher & Paykel Healthcare Corporation Ltd Historical Marketcap From 2015 to 2026
Between 2015 and today, Fisher & Paykel Healthcare Corporation Ltd's market cap moved from $3.04 Billion to $ 12.98 Billion, with a yearly change of 17.02%.
| Year | Market Cap | Change (%) |
|---|---|---|
| 2026 | AU$12.98 Billion | -4.35% |
| 2025 | AU$13.57 Billion | -6.58% |
| 2024 | AU$14.52 Billion | +61.34% |
| 2023 | AU$9.00 Billion | +4.17% |
| 2022 | AU$8.64 Billion | -28.96% |
| 2021 | AU$12.16 Billion | -0.11% |
| 2020 | AU$12.18 Billion | +48.03% |
| 2019 | AU$8.23 Billion | +73.20% |
| 2018 | AU$4.75 Billion | -2.19% |
| 2017 | AU$4.86 Billion | +59.45% |
| 2016 | AU$3.05 Billion | +0.08% |
| 2015 | AU$3.04 Billion | -- |
End of Day Market Cap According to Different Sources
On Apr 18th, 2026 the market cap of Fisher & Paykel Healthcare Corporation Ltd was reported to be:
| Source | Market Cap |
|---|---|
| Yahoo Finance | $12.98 Billion USD |
| MoneyControl | $12.98 Billion USD |
| MarketWatch | $12.98 Billion USD |
| marketcap.company | $12.98 Billion USD |
| Reuters | $12.98 Billion USD |
Market cap values may vary slightly between sources due to differences in calculation methods, timing, and data refresh rates.
About Fisher & Paykel Healthcare Corporation Ltd
Fisher & Paykel Healthcare Corporation Limited, together with its subsidiaries, designs, manufactures, markets, and sells medical device products and systems in North America, Europe, the Asia Pacific, and internationally. It provides its products for use in acute and chronic respiratory care, and surgery, as well as the treatment of obstructive sleep apnea (OSA) in the home and hospital. The com… Read more